Earnings Call · Q3 FY2023·2023-11-09

Q3 23EPS -2.94%·Rev n/aQ2 23EPS +5.71%·Rev n/aQ1 23EPS -8.11%·Rev n/aQ4 22EPS +20.00%·Rev n/a⚠ consensus missing

Adaptive Biotechnologies Corp ADPT

Karina Calzadilla — Investor Relations or similar communications role

Chad Robins — Chief Executive Officer

−4.9%1d on move date−4.1% vs SPY3d−23.4%5d−5.1%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ADPT calls or request research access.

More ADPT calls Browse calls Request research access